The Skin Cancer Myth: What Sunscreen Can and Cannot Do for Indians

When did you last buy a sunscreen because you were genuinely worried about skin cancer — and not because an influencer made you feel like skipping it was an act of negligence against your own skin? 

It is worth sitting with that question. Because somewhere in the last five years, the Indian skincare conversation made a quiet but consequential shift. Sunscreen stopped being sold as something that prevents tanning and started being sold as something that prevents cancer. The stakes went up. The anxiety went up with it. And so, predictably, did the market. 

India's sunscreen industry is growing at a double-digit pace, riding a wave of consumer education that is, at best, selectively accurate. The dermatologists treating Indian patients have a more honest story to tell. It begins with a question the market would rather not answer: for Indian skin specifically, what does sunscreen actually protect against? 

The Body's Own Defence 

Before sunscreen enters the picture, something else is already working. Indian skin — classified under Fitzpatrick types IV through VI, the melanin-rich spectrum that describes the majority of the country's population — is not biologically defenceless against UV radiation. Melanin is an active system. It absorbs UV rays, scatters radiation, and neutralises the free radicals responsible for cellular damage. 

Dr. Malla Devi of Apollo Clinic gives this natural protection a concrete number: Indian skin's melanin content provides a baseline SPF of approximately 13. That is not marginal. It also does not make sunscreen redundant — but it fundamentally changes the risk calculation that sunscreen marketing almost never pauses to acknowledge. "Sunscreen application has higher benefits in fair-skinned than in darker-skinned individuals," she says. 

This is not a fringe position. It follows directly from the biology. And yet it is a statement you are unlikely to encounter in any sunscreen campaign targeted at Indian consumers. 

What the Numbers Actually Say 

Skin cancer in India is rare by global standards. Dr. Saguna Puttoo, Consultant Senior Dermatologist at Apollo Clinic, puts the figure in context: the absolute incidence of melanoma in India sits below 1 to 2 per 100,000 people annually, with non-melanoma skin cancers also relatively uncommon compared to Western populations. In real-world Indian conditions, she notes, "sunscreen likely contributes a relative risk reduction, but the absolute benefit in India is small for skin cancer prevention." 

This is not a reason for complacency. Dr. Shefali Mahlawat of NIIMS Medical College in Greater Noida raises a concern that points in the opposite direction: "In India, there is delayed diagnosis for squamous cell carcinoma and melanomas mainly because of inadequate knowledge about these diseases." The public health problem here is not that Indians are ignoring sunscreen. It is that awareness about what actual skin cancer looks like remains dangerously low. 

More SPF anxiety does not solve that problem. Early detection education does. 

Skin Cancer Is Not Simply a Sun Problem 

This is perhaps the most important thing the marketing conversation leaves out entirely: skin cancer is not caused by UV exposure alone. It develops through the interaction of UV exposure with a set of biological variables that differ significantly from person to person. 

Dr. Mahlawat explains the complexity clearly: "Many people who receive lots of ultraviolet rays throughout their lives do not suffer from skin cancer due to various reasons — good DNA repair, enhanced melanin barrier, immune response which destroys mutated cells, and genetic predisposition to or resistance against the development of cancer." 

Dr. Puttoo adds the mechanism of photoadaptation — the skin's own adaptive response to chronic exposure, through which the outer layer gradually thickens and melanisation increases. "Skin cancer is not solely a function of UV dose," she says. "It reflects the interaction between environmental exposure and host biology." 

Dr. Amit Bhasin, Founder of Privè Luxe, articulates what this means from a practitioner's perspective: "It's less about a single cause and more about how multiple factors interact over time." Coming from within the skincare industry itself, that acknowledgement carries particular weight. 

Dr. Devi makes the sharpest illustration of this multi-factor reality: "Farmers may never get skin cancer, while an indoor worker with genetic risk might." Decades of outdoor exposure do not automatically produce malignancy. Genetic susceptibility, immune function, the nature of exposure — intermittent versus chronic, with or without burning — and factors including HPV infection and immunosuppression all determine who actually develops the disease. 

Sunscreen addresses one variable in this system. It does not address the system. 

So What Does Sunscreen Actually Do For Most Indians? 

The doctors here are not anti-sunscreen. They are anti-overclaim. And what they consistently point toward is a more accurate account of what sunscreen genuinely delivers for the average Indian adult. 

Dr. Puttoo is unambiguous on the medical question: "For the average Indian individual without specific risk factors, daily sunscreen use is not strictly necessary for skin cancer prevention." Its practical benefit, she says, is more visible elsewhere — in reducing pigmentation, controlling melasma, and slowing photoageing. 

Dr. Mahlawat draws the medical boundary with precision. Sunscreen is genuinely necessary for people with photodermatosis, pre-malignant lesions, post-procedure skin following peels or laser treatments, and those on photosensitising medications. For everyone else, the category shifts. "For the general population that mostly engages in indoor activities," she says, "sunscreen use can be seen as both preventive care and a cosmetic procedure." 

Dr. Devi states the distinction most plainly: "If your goal is preventing discoloration and aging, it's cosmetic. If your goal is preventing malignancy in a high-risk individual, it's medical." 

Dr. Bhasin offers the industry framing that bridges both sides: "Rather than viewing it as one or the other, it's more accurate to see sunscreen as a protective habit with both functional and aesthetic value, depending on the individual's needs." The cosmetic case for sunscreen in India — managing melasma, uneven pigmentation, premature ageing — is real and legitimate. It simply should not be dressed up as something it is not. 

The Misconceptions Running Loose 

Several specific beliefs have embedded themselves deeply in consumer culture, and they are worth naming directly. 

The idea that higher SPF numbers offer proportionally better protection is false. SPF 30 filters approximately 97% of UVB radiation; SPF 50 filters about 98%; SPF 100 reaches roughly 99%. The incremental gain above SPF 50 is marginal. Dr. Devi flags this as one of the most persistent overestimations in the market — a belief that is, conveniently, excellent for premium product sales. 

The idea that a morning application lasts all day is equally false. Sunscreen degrades with sweat, sebum, and friction. Dr. Devi's practical guidance: reapply after three or more hours of outdoor exposure. This detail rarely receives the same emphasis as the morning ritual in most communication — because foregrounding it would complicate the simplicity of the habit being sold. 

On the other side, the belief that dark skin is immune to sun damage is its own error. UVA radiation — responsible for ageing and pigmentation — penetrates deeply regardless of melanin levels. Dr. Puttoo notes that delayed diagnosis in darker skin can worsen outcomes when cancer does occur. Lower risk is not the same as no risk, and dismissing sun protection entirely is as inaccurate as overstating its necessity. 

What Good Sun Protection Actually Looks Like 

Dr. Puttoo's clinical framework inverts the hierarchy most consumers have absorbed from marketing. Behavioural change comes first: avoid peak UV hours between 10 am and 3 pm, especially in high UV index regions. Physical protection — clothing, hats, shade — is more consistently reliable than topical products, because it does not depend on correct application or timely reapplication. Sunscreen works best as one component within this broader system. 

Her summary of sunscreen's true position is precise: it is "an adjunct — important in specific contexts, but not a singular or universally mandatory intervention for skin cancer prevention." 

Dr. Bhasin echoes this from a product standpoint: "Sunscreen does contribute to reducing cumulative UV damage over time" — but in everyday Indian conditions, its role in directly lowering skin cancer risk is modest. Where it makes a more visible difference, he says, is in preventing tanning, pigmentation, and photoageing. 

For practical use, Dr. Devi's guidance is straightforward: broad-spectrum SPF 30 to 50, applied in a quantity roughly equivalent to two finger-lengths for the face, reapplied after extended outdoor exposure. Not as a cancer shield for the general population — but as a tool for maintaining even skin tone and slowing visible ageing, which are real, sufficient reasons in themselves. 

The Question Worth Asking 

The problem with how sunscreen is currently positioned for Indian consumers is not that the product is ineffective. It is that the risk narrative being used to sell it has been borrowed from a different population, a different skin biology, and a different epidemiological context — and applied here without adjustment. 

Indian skin has biology working in its favour. Skin cancer in this population is genuinely rare. The primary benefits of sunscreen for most Indians are cosmetic in the clinical sense — meaningful, valid, worth pursuing, but not the same as medical necessity. And the rare cases that do occur demand better diagnostic awareness, not more purchase anxiety. 

Knowing the difference is not a reason to abandon SPF. It is a reason to use it for the right reasons — and to stop being afraid on behalf of someone else's skin.